Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Palmer, J. P.
Right arrow Articles by Brooks-Worrell, B. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Palmer, J. P.
Right arrow Articles by Brooks-Worrell, B. M.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes 54:S62-S67, 2005
© 2005 by the American Diabetes Association, Inc.


Section II: Type 1-Related Forms of Diabetes

Is Latent Autoimmune Diabetes in Adults Distinct From Type 1 Diabetes or Just Type 1 Diabetes at an Older Age?

Jerry P. Palmer1,2, Christiane S. Hampe1, Harvey Chiu1,2, Amit Goel1,2, and Barbara M. Brooks-Worrell1,2

1 Department of Medicine, Division of Metabolism, Endocrinology and Nutrition, University of Washington, Seattle, Washington
2 Department of Veterans Affairs Puget Sound Health Care System, Seattle, Washington

Diabetes is classified clinically into two types: type 1 and type 2 diabetes. Type 1 diabetes is an autoimmune diabetes, whereas, in contrast, type 2 diabetes is nonautoimmune. However, there is a group of phenotypic adult type 2 diabetic patients (~10%) who have islet autoantibodies similar to type 1 diabetes. These patients are said to have latent autoimmune diabetes in adults (LADA) or type 1.5 diabetes. T-cells reacting with islet proteins have been demonstrated in type 1 and type 1.5 diabetic patients. In contrast, classic autoantibody-negative type 2 diabetic patients are also negative for T-cell responses to islet proteins. Therefore, we questioned whether type 1 and type 1.5 diabetes are similar or different autoimmune diseases. We have investigated the immunological and metabolic differences between type 1, type 1.5, and classic type 2 diabetic patients. We have identified autoantibody differences, differences in islet proteins recognized by T-cells, and differences in insulin resistance. We have also identified a small group of patients who have T-cells responsive to islet proteins but who are autoantibody negative. These patients appear to be similar to type 1.5 patients in having decreased stimulated C-peptide values. These immunological differences between type 1 and type 1.5 diabetes suggest at least partially distinct disease processes.


Address correspondence and reprint requests to Jerry P. Palmer, MD, DVA Puget Sound Health Care System, Endocrinology (111), 1660 S. Columbian Way, Seattle, WA 98108. E-mail: jpp{at}u.washington.edu

Abbreviations: GADA, GAD antibody; ICA, islet cell antibody; LADA, latent autoimmune diabetes in adults; MICA, major histocompatibility complex class I chain–related gene A


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
DiabetesHome page
C. Tiberti, C. Giordano, M. Locatelli, E. Bosi, G. F. Bottazzo, R. Buzzetti, D. Cucinotta, A. Galluzzo, A. Falorni, and F. Dotta
Identification of Tyrosine Phosphatase 2(256-760) Construct as a New, Sensitive Marker for the Detection of Islet Autoimmunity in Type 2 Diabetic Patients: The Non-Insulin Requiring Autoimmune Diabetes (NIRAD) Study 2
Diabetes, May 1, 2008; 57(5): 1276 - 1283.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
A. Goel, H. Chiu, J. Felton, J. P. Palmer, and B. Brooks-Worrell
T-Cell Responses to Islet Antigens Improves Detection of Autoimmune Diabetes and Identifies Patients With More Severe {beta}-Cell Lesions in Phenotypic Type 2 Diabetes
Diabetes, August 1, 2007; 56(8): 2110 - 2115.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
A Mayer, N Fabien, M C Gutowski, V Dubois, L Gebuhrer, J Bienvenu, J Orgiazzi, and A M Madec
Contrasting cellular and humoral autoimmunity associated with latent autoimmune diabetes in adults
Eur. J. Endocrinol., July 1, 2007; 157(1): 53 - 61.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
H. BEYAN, T. OLA, R DAVID, and G LESLIE
Progression of Autoimmune Diabetes: Slowly Progressive Insulin-Dependent Diabetes Mellitus or Latent Autoimmune Diabetes of Adult
Ann. N.Y. Acad. Sci., October 1, 2006; 1079(1): 81 - 89.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
R. J. Chaparro, Y. Konigshofer, G. F. Beilhack, J. A. Shizuru, H. O. McDevitt, and Y.-h. Chien
Nonobese diabetic mice express aspects of both type 1 and type 2 diabetes
PNAS, August 15, 2006; 103(33): 12475 - 12480.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2005 by the American Diabetes Association.